Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

This study has been completed.
Sponsor:
Collaborator:
University of Turin, Italy
Information provided by (Responsible Party):
Paolo Zola, Azienda Ospedaliera San Giovanni Battista
ClinicalTrials.gov Identifier:
NCT01523652
First received: July 5, 2011
Last updated: January 30, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):